Adriana Tron

Adriana Tron has extensive experience in oncology and cancer research, having held senior leadership positions in several prominent organizations. At Servier Pharmaceuticals, Adriana served as Senior Director and Director of Translational Medicine Oncology from April 2021 to March 2024. Prior to that, Adriana worked at Agios Pharmaceuticals as Director and Associate Director of Cancer Biology from June 2019 to April 2021. At AstraZeneca, Adriana progressed from Senior Scientist to Associate Principal Scientist in Cancer Research between December 2013 and June 2019. Adriana's academic background includes serving as an Instructor in Medicine at Harvard Medical School and completing a post-doctoral fellowship at Dana-Farber Cancer Institute. Adriana holds a PhD with honors in Biological Sciences and a Bachelor's degree with honors in Biochemistry from Universidad Nacional del Litoral.